, 44:907 | Cite as

Regulation of HMGCoA Reductase Activity by Policosanol and Octacosadienol, a New Synthetic Analogue of Octacosanol

  • Simonetta Oliaro-Bosso
  • Emanuela Calcio Gaudino
  • Stefano Mantegna
  • Enrico Giraudo
  • Claudia Meda
  • Franca Viola
  • Giancarlo Cravotto
Original Article


Octacosa-10,19-dien-1-ol is a newly synthesized long-chain alcohol, an unsaturated analogue of 1-octacosanol, the major component of policosanol, the purified natural mixture of different higher aliphatic alcohols obtained from sugarcane wax. Our efficient synthetic protocol (five steps with 50% overall yield) is well suited for gram scale preparations and a rapid generation of analogues with different degrees of unsaturation. Beneficial effects of policosanol in the prevention of atherosclerosis and thromboembolic disorders have been reported and related to the inhibition of sterol biosynthesis possibly by the regulation of the activity of HMGCoA reductase mediated by AMP-dependent kinase AMPK. We have compared the effect of octacosadienol and policosanol on the regulation of HMGCoA reductase in HUVEC and HepG2 human hepatoma cells. Octacosadienol was as effective as policosanol in inhibiting the upregulation of HMGCoA reductase, in inducing the phosphorylation of AMPK and in downregulating the HMGCoA reductase mRNA.


Long-chain alcohols synthesis Octacosadienol Octacosanol HMGCoA reductase Policosanol AMPK phosphorylation 



AMP-activated protein kinase


Dulbecco-modified Eagle medium


Ethylenediaminetetraacetic acid


Ethylene glycol tetraacetic acid


HydroxyMethylGlutaryl-Coenzyme A reductase


Human endothelial cells from umbilical cord veins


Low density lipoproteins


Lipid-depleted medium


Phosphate-buffered saline


Real time-polymerase chain reaction


Sodium dodecyl sulfate




  1. 1.
    Houtz RL, Ries SK, Tolbert NE (1985) Effect of triacontanol on Chlamydomonas. II. Specific activity of ribulose-bisphosphate carboxylase/oxygenase, ribulose-bisphosphate concentration, and characteristics of photorespiration. Plant Physiol 79:365–370CrossRefPubMedGoogle Scholar
  2. 2.
    Lesniak AP, Haug A, Ries SK (1986) Stimulation of ATPase activity in barley (Hordeum vulgare) root plasma membrane after treatment of intact tissues and cell free extracts with triacontanol. Physiol Plant 68:20–26CrossRefGoogle Scholar
  3. 3.
    Mc Bride PT, Clark I, Krueger GG (1987) Evaluation of triacontanol-containing compounds as anti-inflammatory agents using guinea pig models. J Invest Dermatol 89:380–383CrossRefGoogle Scholar
  4. 4.
    Saint-John M, McNaughton L (1986) Octacosanol ingestion and its effects on metabolic responses to submaximal cycle ergometry, reaction time and chest and grip strength. Int Clin Nutr Rev 6:81–87Google Scholar
  5. 5.
    Ohia Y, Ohashi K, Matsura T, Tokunaga K, Kitagawa A, Yamada K (2008) Octacosanol attenuates disrupted hepatic reactive oxygen species metabolism associated with acute liver injury progression in rats intoxicated with carbon tetrachloride. J Clin Biochem Nutr 42:118–125CrossRefGoogle Scholar
  6. 6.
    Sho H, Chinen I, Fukuda N (1984) Effect of Okinawan sugar cane wax and fatty alcohol on serum and liver lipids in the rat. J Nutr Sci Vitaminol 30:539–553Google Scholar
  7. 7.
    Shimura S, Hasegawa T, Takano S, Suzuki T (1987) Studies on the effect of octacosanol on motor endurance in mice. Nutr Rep Int 36:1029–1038Google Scholar
  8. 8.
    Irmak S, Dunford NT, Milligan J (2005) Policosanol contents of beeswax, sugar cane and wheat extracts. Food Chem 95:312–318CrossRefGoogle Scholar
  9. 9.
    Kazuko K, Kumlko A, Yohel H (1991) Free primary alcohols in oils and waxes from germs, kernels and other components of nuts, seeds, fruits and cereals. J Am Oil Chem Soc 68:869–872CrossRefGoogle Scholar
  10. 10.
    Piatak DM, Reimann KA (1970) Isolation of 1-octacosanol from Euphorbia corollata. Phytochemistry 9:2585–2586CrossRefGoogle Scholar
  11. 11.
    Hernandez F, Illnait J, Mas R, Castano G, Fernandez L, Gonzalez M, Cordovi N, Fernandez J (1992) Effect of policosanol on serum lipids and lipoproteins in healthy volunteers. Curr Ther Res 51:568–575Google Scholar
  12. 12.
    Menéndez R, Fernández I, Del Río A, Gónzalez RM, Fraga V, Amor AM, Más R (1994) Policosanol inhibits cholesterol biosynthesis and enhances low-density lipoprotein processing in cultured human fibroblasts. Biol Res 27:199–203CrossRefPubMedGoogle Scholar
  13. 13.
    Menéndez R, Amor A, Rodeiro I, Gonzalez RM, Gonzalez PC, Alfonso JL, Mas R (2001) Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts. Arch Med Res 32:8–12CrossRefPubMedGoogle Scholar
  14. 14.
    Menéndez R, Arruzazabala L, Mas R, Del Rio A, Amor AM, Gonzalez RM, Carbajal D, Fraga V, Molina V, Illnait J (1997) Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolemia induced by a wheat starch–casein diet. Br J Nutr 77:923–932CrossRefPubMedGoogle Scholar
  15. 15.
    Menéndez R, Amor AM, González RM, Fraga V, Mas R (1996) Effect of policosanol on the hepatic cholesterol biosynthesis of normocholesterolemic rats. Biol Res 29:253–257PubMedGoogle Scholar
  16. 16.
    Berthold IG, Berthold HK (2002) Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am Heart J 143:356–365CrossRefPubMedGoogle Scholar
  17. 17.
    Viola F, Oliaro S, Binello A, Cravotto G (2008) Policosanol: updating and perspectives. Mediterr J Nutr Metab 1:77–83CrossRefGoogle Scholar
  18. 18.
    Kassis A, Jones PJH (2006) Lack of cholesterol-lowering efficacy of Cuban sugar cane policosanol in hypercholesterolemic persons. Am J Clin Nutr 84:1003–1008PubMedGoogle Scholar
  19. 19.
    Dulin MF, Hatcher LF, Sasser HC, Barringer T (2006) Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial. Am J Clin Nutr 84:1543–1548PubMedGoogle Scholar
  20. 20.
    Berthold HK, Unverdorben S, Degenhardt R, Gouni-Berthold I (2006) Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia. J Am Med Assoc 295:2262–2269CrossRefGoogle Scholar
  21. 21.
    Kassis AN, Kubow S, Jones PJH (2009) Sugar cane policosanols do not reduce LDL oxidation in hypercholesterolemic individuals. Lipids 44:391–396CrossRefPubMedGoogle Scholar
  22. 22.
    Singh DK, Li L, Porter TD (2006) Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. J Pharmacol Exp Ther 318:1020–1026CrossRefPubMedGoogle Scholar
  23. 23.
    Keller S, Gimmler F, Jahreis G (2008) Octacosanol administration to humans decreases neutral sterol and bile acid concentration in feces. Lipids 43:109–115CrossRefPubMedGoogle Scholar
  24. 24.
    Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425–430CrossRefPubMedGoogle Scholar
  25. 25.
    Hardie DG, Carling D, Carlson M (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67:821–855CrossRefPubMedGoogle Scholar
  26. 26.
    Hardie DG (2004) The AMP-activated protein kinase pathway—new players upstream and downstream. J Cell Sci 117:5479–5487CrossRefPubMedGoogle Scholar
  27. 27.
    Motoshima H, Goldstein BJ, Igata M, Araki E (2006) AMPK and cell proliferation—AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol 574:63–71CrossRefPubMedGoogle Scholar
  28. 28.
    Hadad SM, Fleming S, Thompson AM (2008) Targeting AMPK: a new therapeutic opportunity in breast cancer. Crit Rev Oncol Hematol 67:1–7CrossRefPubMedGoogle Scholar
  29. 29.
    Takahashi HK, Nishibori M (2007) The antitumour activities of statins. Curr Oncol 14:246–247CrossRefPubMedGoogle Scholar
  30. 30.
    Ho PL, Liang YC, Ho HS, Chen CT, Lee WS (2004) Inhibition of human vascular endothelial cells proliferation by terbinafine. Int J Cancer 111:51–59CrossRefPubMedGoogle Scholar
  31. 31.
    Curtis R, Chong CR, Xu J, Lu J, Bhat S, Sullivan DJ Jr, Liu JO (2007) Inhibition of angiogenesis by the antifungal drug itraconazole. ACS Chem Biol 2:263–270CrossRefGoogle Scholar
  32. 32.
    Thippeswamy G, Sheela MI, Salimath BP (2008) Octacosanol isolated from Tinospora cordifolia downregulates VEGF gene expression by inhibiting nuclear translocation of NF-kappaNB and its DNA binding activity. Eur J Pharmacol 588:141–150CrossRefPubMedGoogle Scholar
  33. 33.
    Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119:629–641CrossRefPubMedGoogle Scholar
  34. 34.
    Chan BE, Knowles BR (1976) A solvent system for delipidation of plasma or serum without protein precipitation. J Lipid Res 17:176–181Google Scholar
  35. 35.
    Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346–356CrossRefPubMedGoogle Scholar
  36. 36.
    Zang M, Zuccollo A, Hou X, Nagata D, Walsh K, Herscovitz H, Brecher P, Ruderman NB, Cohen RA (2004) AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol chem 279:47898–47905CrossRefPubMedGoogle Scholar
  37. 37.
    Aviva P, Sabin C (2000) Medical statistics at a glance, Blackwell Science Ltd., Padstow, UKGoogle Scholar
  38. 38.
    Cravotto G (2003) A process for preparing long chain saturated or unsaturated oxygenated compounds. Patent WO/2003/106397; Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field. Patent WO/2003/105822Google Scholar
  39. 39.
    Cravotto G, Binello A, Merizzi G, Avogadro M (2004) Improving solvent-free extraction of policosanol from rice bran by high-intensity ultrasound treatment. Eur J Lipid Sci Technol 106:147–151CrossRefGoogle Scholar
  40. 40.
    Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167–1174PubMedGoogle Scholar
  41. 41.
    Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real time quantitative PCR and the 2t−ΔΔC method. Methods 25:402–408CrossRefPubMedGoogle Scholar
  42. 42.
    Graaf MR, Richel DJ, van Noorden CJF, Guchelaar HJ (2004) Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer. Cancer Treat Rev 30:609–641CrossRefPubMedGoogle Scholar
  43. 43.
    Tang CH, Chiu YC, Tan TW, Yang RS, Fu WM (2007) Adiponectin enhances IL-6 production in human synovial fibroblast via an adipoR1 receptor, AMPK, p38, and NF-kB pathway. J Immunol 179:5483–5492PubMedGoogle Scholar
  44. 44.
    Escarcega RO, Fuentes-Alexandro S, Garcıa-Carrasco M, Gatica A, Zamora A (2007) The transcription factor nuclear factor-kappa B and cancer. Clin Oncol 19:154–161CrossRefGoogle Scholar

Copyright information

© AOCS 2009

Authors and Affiliations

  • Simonetta Oliaro-Bosso
    • 1
  • Emanuela Calcio Gaudino
    • 1
  • Stefano Mantegna
    • 1
  • Enrico Giraudo
    • 2
  • Claudia Meda
    • 2
  • Franca Viola
    • 1
  • Giancarlo Cravotto
    • 1
  1. 1.Dipartimento di Scienza e Tecnologia del FarmacoUniversity of TorinoTorinoItaly
  2. 2.Department of Oncological Sciences, Institute for Cancer Research and TreatmentUniversity of Torino School of MedicineCandioloItaly

Personalised recommendations